18945-36-3Relevant articles and documents
The application of the phosphoramidate ProTide approach confers micromolar potency against Hepatitis C virus on inactive agent 4′-azidoinosine: Kinase bypass on a dual base/sugar modified nucleoside
McGuigan, Christopher,Daverio, Felice,Najera, Isabel,Martin, Joseph A.,Klumpp, Klaus,Smith, David B.
scheme or table, p. 3122 - 3124 (2010/02/28)
Novel phosphoramidate ProTides derived from 4′-azidoinosine have been prepared and evaluated in the replicon assay against hepatitis C Virus (HCV). The parent nucleoside analogue is inactive in this assay, while the ProTides are active at low μM levels in